Financial News
All News about Pear Therapeutics, Inc. - Class A Common Stock
![](https://mms.businesswire.com/media/20230126005206/en/1696308/5/BV_Logo_CMYK_Horizontal.jpg)
![](https://mms.businesswire.com/media/20230118005318/en/754943/22/Logo-Pear-Therapeutics-Final.jpg)
Pear Therapeutics's Return On Capital Employed Insights
December 26, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20230117005429/en/754943/22/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20230112005160/en/754943/22/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20230110005453/en/1681523/5/COEUS_HEALTHCARE_Logo_RGB.jpg)
![](https://mms.businesswire.com/media/20230104005238/en/1676028/5/Spero_Health_Logo_M_CMYK.jpg)
12 Health Care Stocks Moving In Monday's After-Market Session
December 26, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20221215005368/en/754943/22/Logo-Pear-Therapeutics-Final.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23992.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221121005020/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/17/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/16/image-target_corporation_0.png?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 16, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20221114005975/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
Pear Therapeutics Reports Third Quarter 2022 Results
November 14, 2022
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/11/15/image42.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9842.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221110005213/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
Pear Therapeutics to Participate in the BTIG Digital Health Forum
November 10, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221107005424/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20221103005476/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20221101005909/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20221031005486/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/25/image_2.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221024005254/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/19/image-netflix.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/19/image_3.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220913005256/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
Pear Therapeutics to Participate in LifeSci Partners HealthTech Symposium
September 13, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220907005386/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/12/image_1.jpg?width=1200&height=800&fit=crop)
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
September 12, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.